CMS Expands Access to Non-Invasive Ventilation for COPD Patients: What Suppliers Need to Know

Published in Member Communities on August 25, 2026

By Kelly Grahovac, General Manager, The van Halem Group

The Centers for Medicare & Medicaid Services (CMS) has implemented a landmark National Coverage Determination (NCD) that broadens access to non-invasive positive pressure ventilation (NIPPV) for Medicare beneficiaries suffering from chronic respiratory failure (CRF) secondary to chronic obstructive pulmonary disease (COPD). Effective June 9, 2025, the policy introduces new national coverage standards for respiratory assist devices (RADs) and home mechanical ventilators (HMVs), providing long-awaited clarity for clinicians, suppliers, and patients alike.

This change represents one of the most significant updates to respiratory equipment coverage in recent years. While the new NCD creates additional opportunities for patients to receive medically necessary therapy, it also introduces new responsibilities for durable medical equipment (DME) suppliers. Success under the new framework will require careful planning, staff education, documentation oversight, and a heightened focus on patient compliance.

A Significant Step Forward for COPD Patients

Chronic respiratory failure is a serious and progressive condition that affects many individuals living with advanced COPD. For years, providers and suppliers have faced varying interpretations of coverage requirements, creating challenges in obtaining timely access to respiratory support equipment for qualified patients.

The new NCD establishes nationally consistent criteria for coverage of both RADs and HMVs when used for the treatment of CRF caused by COPD.

By defining specific clinical requirements, CMS has sought to reduce ambiguity and provide a more predictable pathway to coverage.

For patients, this means improved access to therapies that can help reduce symptoms, support respiratory function, decrease hospitalizations, and improve overall quality of life. For healthcare providers, the decision creates a clearer framework for determining when non-invasive ventilation is medically appropriate.

Payment Structures Remain Unchanged

While the coverage criteria have evolved, suppliers should note that Medicare’s payment methodology for these devices remains unchanged.

Respiratory assist devices (RADs) continue to fall under the capped rental payment category. Under this structure, Medicare pays monthly rental amounts for up to 13 months. After the rental period is completed, ownership of the equipment transfers to the beneficiary. Supplies associated with RAD therapy, such as tubing, masks, and other accessories, remain separately billable and payable according to existing Medicare guidelines.

Home mechanical ventilators (HMVs), often referred to as non-invasive ventilators (NIVs), remain in the frequent and substantial servicing (FSS) payment category. Unlike capped rental equipment, these devices do not convert to beneficiary ownership after a specific rental period. Instead, Medicare continues to make monthly rental payments for as long as the equipment remains medically necessary. Supplies and servicing are included within the monthly allowable amount and are not separately reimbursed.

Because the reimbursement structure has not changed, suppliers must carefully evaluate operational costs associated with implementing the new requirements. While expanded coverage may increase patient access, it does not provide additional reimbursement to offset increased administrative responsibilities.

Key Advantages of the New NCD

The new policy includes several important improvements that are expected to benefit both patients and providers.

Standardized Criteria

Perhaps the most significant advancement is the establishment of clearer clinical criteria for home non-invasive ventilation. Previously, inconsistent interpretations and varying documentation expectations often resulted in delays, denials, and appeals. Nationally standardized criteria should help streamline the qualification process and improve consistency across the Medicare program.

Removal of Certain Testing Requirements

Another notable benefit is the removal of certain testing requirements for RAD coverage. Under the revised framework, patients seeking qualifying RAD therapy for COPD-related chronic respiratory failure are no longer subject to oximetry or sleep study requirements that were often burdensome and difficult to coordinate. Eliminating these barriers may allow eligible patients to begin therapy more quickly while reducing unnecessary delays in treatment.

More Clinical Evidence

The NCD also acknowledges the growing body of clinical evidence supporting the use of non-invasive ventilation in appropriately selected COPD patients. By aligning coverage with current clinical practice, CMS has recognized the value of these therapies in managing chronic respiratory disease.

New Challenges for Suppliers

Although the NCD presents clear opportunities, it also creates several operational challenges that suppliers must address.

Documentation Requirements

One of the most immediate concerns is the increase in documentation requirements. While the criteria may be clearer, suppliers will need to ensure that clinical records fully support coverage and demonstrate continued medical necessity. Documentation review will become increasingly important as suppliers work to remain compliant with Medicare requirements.

More Responsibility, No Additional Reimbursement

Additionally, suppliers are being asked to take on greater responsibility without additional reimbursement. The resources required to monitor patient outcomes, collect compliance data, educate referral sources, and maintain accurate records can be substantial. Organizations that fail to develop efficient processes may find that administrative burdens negatively impact profitability and staff productivity.

Referral Source Education

Referral source education is another critical area. Physicians, respiratory therapists, discharge planners, and other healthcare professionals may not yet be familiar with the specifics of the new NCD. Suppliers that proactively engage referral partners can help ensure appropriate documentation is obtained at the outset, reducing delays and preventing claim denials.

Increased Focus on Patient Compliance

Perhaps the most important operational consideration for suppliers is the NCD’s emphasis on patient adherence.

The policy establishes ongoing compliance requirements that extend beyond the initial qualification process. According to the NCD, patients must use the device for at least four hours during a 24-hour period on 70 percent of days in each paid rental month.

This requirement shifts compliance from a one-time event to an ongoing responsibility.

Suppliers must now develop processes to monitor usage regularly, identify potential compliance issues early, and intervene when patients demonstrate declining adherence.

Failure to meet utilization requirements could jeopardize ongoing coverage and reimbursement. As a result, suppliers need systems capable of consistently tracking patient usage data and documenting adherence throughout the rental period.

For organizations that have historically managed compliance monitoring manually, the increased volume of patients may quickly overwhelm staff resources. Developing a sustainable strategy for compliance management is therefore essential.

Preparing for Additional Guidance

Another area that warrants close attention is the forthcoming guidance from the Durable Medical Equipment Medicare Administrative Contractors (DME MACs).

The NCD establishes the national coverage framework, but many operational details still require clarification. The DME MACs are actively developing Local Coverage Determinations (LCDs) and related policy articles that will provide additional instruction for implementing the new requirements.

These documents are expected to address areas where CMS has granted contractor discretion, including:

Documentation expectations
Coverage interpretation
Claims processing considerations

Suppliers should monitor policy updates closely and be prepared to adjust workflows as additional information becomes available. Staying informed will be critical to avoiding compliance risks and maintaining uninterrupted reimbursement.

Building a Sustainable Compliance Strategy

Given the ongoing monitoring requirements, suppliers should begin evaluating their internal capabilities now.

A successful compliance program will likely include several key components:

Staff training on the new coverage criteria
Regular review of patient usage reports
Proactive patient outreach and education
Documentation audits and quality assurance processes
Referral source education programs
Escalation procedures for non-compliant patients

For some suppliers, particularly those experiencing rapid growth or serving large respiratory patient populations, outsourcing compliance monitoring may be a practical solution. Reputable third-party monitoring companies can provide technology, reporting, and patient engagement services that help suppliers meet policy requirements while reducing internal administrative burdens.

Whether compliance management is handled internally or through a trusted partner, suppliers should ensure that processes are both effective and scalable.

Looking Beyond Traditional Medicare

While the NCD directly applies to Medicare Fee-for-Service beneficiaries, suppliers should not limit their attention to Medicare alone.

Historically, many commercial insurers and Medicare Advantage plans evaluate CMS coverage decisions when updating their own policies. Early indications suggest that some payers have already begun incorporating elements of the new COPD-related ventilation criteria into their existing coverage frameworks.

As a result, suppliers should closely monitor policy updates across all payer categories. Consistency cannot be assumed, and requirements may vary significantly from one insurer to another during the transition period.

Organizations that maintain awareness of evolving payer policies will be better positioned to avoid claim denials and ensure continuity of care for patients.

Conclusion

The June 2025 National Coverage Determination represents a transformative development in the treatment of chronic respiratory failure secondary to COPD. By expanding access to non-invasive ventilation and establishing clearer coverage standards, CMS has created new opportunities for patients to receive life-changing respiratory support.

However, expanded access comes with increased accountability. Suppliers must be prepared to navigate enhanced documentation expectations, educate referral sources, monitor patient compliance, and adapt to forthcoming DME MAC guidance. Because reimbursement structures remain unchanged, operational efficiency will play a critical role in long-term success.

The organizations that invest in education, workflow optimization, and proactive compliance management today will be best positioned to thrive under the new requirements. As additional payer policies evolve and implementation guidance emerges, suppliers who remain informed and adaptable will be able to maximize both patient outcomes and business performance in this new era of respiratory care.

TAGS